. Proportion of Community-Dwelling Individuals Older Than 70 Years Eligible for Lecanemab Initiation: The Gothenburg H70 Birth Cohort Study. Neurology. 2024 May 14;102(9):e209402. Epub 2024 Apr 9 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Leqembi

News

  1. Gaining a Foothold: Amyloid Immunotherapy in Clinical Practice